- Service category
- Formulation development and drug delivery, Pre-clinical development and testing, pre-clinical CRO
Your company? Get access to this profile.
Hutchison Medi Pharma is an entrepreneurial, China-based, global quality drug development company with a rich pipeline, first class R&D leadership and a proven track record.
- 06/06/2012 HMP announces presentations of Sulfatinib and Fruquintinib clinical data at the 2012 ASCO Annual Meeting
- 03/01/2012 HMP initiates Phase I clinical study of its novel c-Met inhibitor Volitinib
You might also be interested in
Sourcing this company's services?Send inquiry anonymously »